Lorna Pierce. To generate free oligosaccharides characteristic of protein misfolding due to...

21
Lorna Pierce

Transcript of Lorna Pierce. To generate free oligosaccharides characteristic of protein misfolding due to...

Lorna Pierce

• To generate free oligosaccharides characteristic of protein misfolding due to treatment with NB-DNJ

• To observe the effect of endomannosidase activity on free oligosaccharides generated by protein misfolding

• To define the pathway for misfolded proteins between the ER, ERGIC and Golgi including Retrograde Transport

-glc I

-glc IICNX/CRT

GT

EDEMSec61

G3M5N1

-glc II

Golgi

ER lumen

ER man I

ER man I

PNGase

Proteasome

Plasma membrane

ER man I

-N2M9G3 -N2M9G2 -N2M9G1

-N2M9

-N2M8

-N2M8G1-3

-N2M8

ERAD

Glycosylation maturation pathway

EnGase & Cytosolic mannosidase

• To generate free oligosaccharides characteristic of protein misfolding due to treatment with NB-DNJ

-N2M9G3 -N2M9G2

-N2M9G1

CNX/CRT

GT

-N2M8

EDEMSec61

-N2M8G1-3

ER lumen

ER man I

ER man I

PNGase

Proteasome

ER man I

-N2M8

EnGase & Cytosolic mannosidase

Endomannosidase Pathway

NB-DNJ Inhibition in the Protein Folding Pathway

G3M5N1

ER ERGIC

cis-Golgi

+

The Endomannosidase pathway

Bulk flow or ERGIC-53 mediated

Retrograde transport

Cytosolic Mannosidase

Endomannosidase

Golgi Mannosidase I

Further Golgi processing to Complex N-links

?

+ NB-DNJ

Minutes20.00 21.00 22.00 23.00 24.00 25.00 26.00 27.00 28.00

G3M5NG3M7N2

G3M5N

G3M7N2

M7N2

The Free Oligosaccharides Generated by the -glucosidase blockage Caused

by NB-DNJ1mM NB-DNJ 24 hours

1mM NB-DNJ 24 hours, followed by 24 hours with no inhibitor

• To generate free oligosaccharides characteristic of protein misfolding due to treatment with NB-DNJ

• To observe the effect of endomannosidase activity on free oligosaccharides generated by protein misfolding

Minutes

20.00 24.00 28.00 32.00 36.00 40.00 44.00

FOS produced on treatment with NB-DNJ in Endomannosidase +/- cells

Control

Functional Endomannosidase (HL60)

Non-utilised Endomannosidase (MDBK)

G3M5N G3M7N2

• In endomannosidase inactive cells the G3M8N2 constituent of a glycoprotein is cleaved to G3M7N2 by Golgi Mannosidase I or ER mannosidase II

• On re-entry to the ER, G3M7N2-containing proteins are acted upon by an ER located PNGase and G3M7N2 is released from its protein as a FOS

• The G3M7N2 FOS is not targeted for EDEM and hence becomes trapped within the ER

• G3M7N2 is a characteristic FOS of protein misfolding in endomannosidase inactive cells

• To generate free oligosaccharides characteristic of protein misfolding due to treatment with NB-DNJ

• To observe the effect of endomannosidase activity on free oligosaccharides generated by protein misfolding

• To define the pathway for misfolded proteins between the ER, ERGIC and Golgi including Retrograde Transport

ER ERGIC

cis-Golgi

+

The Endomannosidase pathway

Bulk flow or ERGIC-53 mediated

Retrograde transport

Cytosolic Mannosidase

Endomannosidase

Golgi Mannosidase I

Further Golgi processing to Complex N-links

?

+ NB-DNJ

Thapsigargin / Brefeldin A

MDBK Cells Incubated with NB-DNJ

Minutes

12.00 13.00 14.00 15.00 16.00 17.00 18.00 19.00 20.00 21.00 22.00 23.00 24.00 25.00 26.00 27.00 28.00

G3M5N

G3M7N2

G3M7N2

G3M5N

1mM NB-DNJ

1mM NB-DNJ and 10M Thapsigargin

0

0.2

0.4

0.6

0.8

1.0

1.2

0 0.01 0.1 1 10 20

Mean G3M5N

Mean G3M7N2

(pm

ol)

per

ug

of

pro

tein

Thapsigargin (µM)

Triglucosylated FOS produced upon treatment with Thapsigargin

Thapsigargin + NBDNJ

-2 -1 0 125

50

75

100

48h +

24h +

6h +

4h +

2h +

1h +

log [Thapsigargin µM]

% o

f co

ntr

ol

leu

cin

e i

nco

rpo

rati

on

Effect of Thapsigargin on Protein Synthesis

MDBK Cells incubated with NB-DNJ

Minutes

12.00 13.00 14.00 15.00 16.00 17.00 18.00 19.00 20.00 21.00 22.00 23.00 24.00 25.00 26.00 27.00 28.00

G3M5NG3M7N2

G3M7N2

G3M5N

1mM NB-DNJ

1mM NB-DNJ and 10µg/ml Brefeldin A

0

0.5

1

1.5

2

2.5

3

3.5

4

0 0.001 0.01 0.1 1 10

Mean G3M5N

Mean G3M7N2

(pm

ol)

per

ug

of

pro

tein

Brefeldin µg/ml

Triglucosylated FOS produced upon treatment with Brefeldin A

Brefeldin + NBDNJ

-3 -2 -1 0

025

50

75

100

125

48h +

24h +

6h +

4h +

2h +

1h +

log [Brefeldin µg/ml]

% o

f co

ntr

ol

leu

cin

e i

nco

rpo

rati

on

Effect of Brefeldin A on Protein Synthesis

•Reduced levels of G3M7N2 following treatment with Thapsigargin and Brefeldin A indicate retrograde transport inhibition

•The reduction in G3M7N2 seen seems independent of effects on flux through the protein synthesis pathway caused by treatment with Thapsigargin and Brefeldin A

•Evidence for a cyclic pathway for glycoproteins between ER and Golgi compartments that is endomannosidase dependent

•Dr T. Butters•Dom Alonzi•Dr D. Neville•With Thanks to Prof Dwek

Effect of 1 mM NBDNJ

0.0

500.0

1000.0

1500.0

2000.0

2500.0

3000.0

3500.0

4000.0

0 6 12 18 24 30 36 42 48

time (h)

leu

cin

e i

nco

rpo

rati

on

(cp

m/µ

g

pro

tein

)

control

+ NB-DNJ